Significant correlations between severe fatty liver and risk factors for metabolic syndrome - PubMed (original) (raw)
Significant correlations between severe fatty liver and risk factors for metabolic syndrome
Pi-Jung Hsiao et al. J Gastroenterol Hepatol. 2007 Dec.
Abstract
Background and aim: It is known that ultrasonography (US) cannot differentiate between non-alcoholic fatty liver disease (NAFLD) and steatohepatitis. However, US can accurately estimate the severity of the steatosis. The clinical significance of severe hepatic fatty change by US has not been explored. The aim of this study was to investigate the relationship between the severity of the fatty liver, classified by US, and the degree of metabolic disorders with insulin resistance.
Methods: In 16 486 Taiwanese patients, severity of fatty change on US was classified as follows: group A (n = 6950), absence of fatty change; group B (n = 8694), mild; and group C (n = 842), severe fatty liver change. Biometabolic parameters included body mass index (BMI), blood pressure (BP), fasting plasma glucose, triglycerides, cholesterol, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and serum creatinine. Nominal logistic regression analysis was used to estimate the odds ratio for different degrees of fatty liver.
Results: The frequencies of obesity, hypertension, glucose intolerance and hypertriglyceridemia were all significantly higher in group C than in group A or B (P < 0.0001), and the mean values of BMI, BP, fasting glucose, triglyceride and ALT were also higher in group C (P < 0.0001). High BMI (>or=30 kg/m(2)) appears to be the most important factor for progression from mild to severe fatty liver in both sexes.
Conclusions: The presence of severe fatty liver by US correlated significantly with the prevalence and degree of hypertension, abnormal glucose and triglyceride metabolism. Patients with severe fatty liver could be at an increased risk of atherosclerotic cardiovascular disease and should be screened regularly for metabolic disorders. The physician may also evaluate ALT and hepatic fat content by US in patients with metabolic syndrome. Evaluating the severity of fatty liver by US may be useful because it correlates with the status of hyperinsulinemia, the risks of developing cardiovascular disease, and the threshold for oxidative stress.
Similar articles
- Predictive factors for pure steatosis in alcoholic patients.
Naveau S, Thaury J, Barri-Ova N, Balian A, Dauvois B, Njiké-Nakseu M, Prévot S, Agostini H, Perlemuter G. Naveau S, et al. Alcohol Clin Exp Res. 2009 Jun;33(6):1104-10. doi: 10.1111/j.1530-0277.2009.00932.x. Epub 2009 Mar 23. Alcohol Clin Exp Res. 2009. PMID: 19382900 - Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, Makaya M, Mizoue T, Kato N, Wickremasinghe AR, de Silva HJ. Dassanayake AS, et al. J Gastroenterol Hepatol. 2009 Jul;24(7):1284-8. doi: 10.1111/j.1440-1746.2009.05831.x. Epub 2009 May 19. J Gastroenterol Hepatol. 2009. PMID: 19476560 - Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
Hsieh MH, Ho CK, Hou NJ, Hsieh MY, Lin WY, Yang JF, Chiu CC, Huang JF, Chang NC, Wang CL, Dai CY, Chuang WL, Yu ML. Hsieh MH, et al. Int J Obes (Lond). 2009 Nov;33(11):1309-17. doi: 10.1038/ijo.2009.172. Epub 2009 Sep 15. Int J Obes (Lond). 2009. PMID: 19752878 - Epidemiology of non-alcoholic fatty liver disease in China.
Fan JG, Farrell GC. Fan JG, et al. J Hepatol. 2009 Jan;50(1):204-10. doi: 10.1016/j.jhep.2008.10.010. Epub 2008 Nov 6. J Hepatol. 2009. PMID: 19014878 Review. - How should we manage patients with non-alcoholic fatty liver disease in 2007?
Chan HL, de Silva HJ, Leung NW, Lim SG, Farrell GC; Asia-Pacific Working Party on NAFLD. Chan HL, et al. J Gastroenterol Hepatol. 2007 Jun;22(6):801-8. doi: 10.1111/j.1440-1746.2007.04977.x. J Gastroenterol Hepatol. 2007. PMID: 17565632 Review.
Cited by
- Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women.
Kim MK, Ahn CW, Nam JS, Kang S, Park JS, Kim KR. Kim MK, et al. Menopause. 2015 Dec;22(12):1323-7. doi: 10.1097/GME.0000000000000503. Menopause. 2015. PMID: 26154274 Free PMC article. - Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.
Juanola O, Martínez-López S, Francés R, Gómez-Hurtado I. Juanola O, et al. Int J Environ Res Public Health. 2021 May 14;18(10):5227. doi: 10.3390/ijerph18105227. Int J Environ Res Public Health. 2021. PMID: 34069012 Free PMC article. Review. - SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.
Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV Jr, Alt FW, Kahn CR, Verdin E. Hirschey MD, et al. Nature. 2010 Mar 4;464(7285):121-5. doi: 10.1038/nature08778. Nature. 2010. PMID: 20203611 Free PMC article. - Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease.
Tahir F, Majid Z, Majid B, Ahmed J, Zaman A, Tariq M, Imtiaz F, Tahir SA. Tahir F, et al. Cureus. 2020 Feb 17;12(2):e7016. doi: 10.7759/cureus.7016. Cureus. 2020. PMID: 32211252 Free PMC article. - Non-alcoholic fatty liver disease: The diagnosis and management.
Abd El-Kader SM, El-Den Ashmawy EM. Abd El-Kader SM, et al. World J Hepatol. 2015 Apr 28;7(6):846-58. doi: 10.4254/wjh.v7.i6.846. World J Hepatol. 2015. PMID: 25937862 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical